Abstract #0673
SUV-ADC mapping of malignant and benign prostate lesions with PET-MRI
Yachao Liu 1 , Jiangping Gao 2 , Jiajin Liu 1 , Hui Liu 3 , Yong Xu 2 , Baixuan Xu 1 , and Jiahe Tian 1
1
Nuclear Medicine Department, PLA 301 General
Hospital, Beijing, Beijing, China,
2
Urology
Department, PLA 301 General Hospital, Beijing, China,
3
NEA
MR Collaboration, Siemens Ltd., China, Shanghai, China
Although 11C-Choline PET/CT has approved a valuable
tools for recurrent prostate cancer detection and
treatment evaluation. However, it is still a problem for
primary prostate cancer. The combined MRI with
11C-Choline PET could be potentially useful for primary
prostate cancer. We are evaluating the combined features
of MRI and PET to improve the diagnostic performance of
primary prostate.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here